Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nokia Corp (NOK) vs Teladoc Health Inc (TDOC) Price & Performance

Nokia CorpTrade
Teladoc Health IncTrade

Price performance (Past 24H)

Key statistics

Nokia Corp vs Teladoc Health Inc — how do they compare? Nokia Corp trades at $10.36 (market cap $56.99B), while Teladoc Health Inc trades at $5.77 (market cap $1.01B). The key difference: Nokia Corp is far larger — about 56.4× Teladoc Health Inc's market cap, and Nokia Corp pays a 1.61% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nokia Corp for 66 Days and Teladoc Health Inc for 39 Days on average.

NOKTDOC
Market Cap
$56.99B$1.01B
Volume
69,968,2044,668,477
Sector
TechnologyHealth
52-Week High
$16.83$9.72
52-Week Low
$5.25$4.47
Typical Hold Time
66 Days39 Days
Enterprise Value
$55.01B$1.27B
Dividend Yield
1.61%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Nokia Corp

Nokia (NOK) trades at $10.14, down 4.52% over 24 hours, with a bearish technical signal. The stock shows mixed earnings, beating estimates in Q4 2025 and Q2 2026 but missing in Q1 2026. Revenue has stabilized around $20B annually, with a net income margin of 3.47% in 2025. Analyst consensus is bullish, with a $17.50 price target, supported by recent partnerships in AI and satellite communications.

The outlook is cautiously optimistic, driven by AI infrastructure demand and strategic alliances, but risks include competitive pressures and volatile cash flows. Upside potential exists if execution on growth initiatives improves profitability, while downside risks stem from macroeconomic headwinds and execution missteps.

Teladoc Health Inc

TDOC trades at $5.54, down 0.36% on the day, with a bearish technical signal and mixed earnings history. The company reported revenue of $2.53B in 2025 but a net loss of $200.32M, reflecting ongoing profitability challenges. Analyst consensus is a 'Hold' with a $8.83 price target, indicating potential upside. Recent news includes a CFO transition and legal investigations, adding to investor uncertainty.

The outlook remains cautious due to persistent losses and competitive pressures, though valuation metrics like P/S of 0.4 and EV/EBITDA of 5.89 suggest the stock is undervalued. Key risks include weak cash flow trends and BetterHelp segment volatility. Upside depends on execution in integrated care and cost management.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NOK
92% Buy8% Sell
Avg holding period · 66 Days
TDOC
100% Buy0% Sell
Avg holding period · 39 Days

Top news

Latest headlines on both assets

About Nokia Corp

Nokia is a leading vendor in the telecommunications equipment industry. The company's network business derives revenue from selling wireless and fixed-line hardware, software, and services. Nokia's technology segment licenses its patent portfolio to handset manufacturers and makes royalties from Nokia-branded cellphones. The company, headquartered in Espoo, Finland, operates on a global scale, with most of its revenue from communication service providers.

Read more on NOK →

About Teladoc Health Inc

Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.

Read more on TDOC →